Prognostic value of serum CYFRA 21-1 1 in patients with anal canal squamous cell carcinoma treated with radio(chemo)therapy.

about

Prognostic value of serum CYFRA 21-1 1 in patients with anal canal squamous cell carcinoma treated with radio(chemo)therapy.

Item

http://www.wikidata.org/entity/Q55220783

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Prognostic value of serum CYFR ...... l carcinoma treated with radio

@nl

Prognostic value of serum CYFR ...... ated with radio(chemo)therapy.

@en

type

Item

label

Prognostic value of serum CYFR ...... l carcinoma treated with radio

@nl

Prognostic value of serum CYFR ...... ated with radio(chemo)therapy.

@en

prefLabel

Prognostic value of serum CYFR ...... l carcinoma treated with radio

@nl

Prognostic value of serum CYFR ...... ated with radio(chemo)therapy.

@en

P1476

Prognostic value of serum CYFR ...... ated with radio(chemo)therapy.

@en

P2093

Astrid Lièvre

http://www.w3.org/2001/XMLSchema#string

Bruno Buecher

http://www.w3.org/2001/XMLSchema#string

Dominique Bellet

http://www.w3.org/2001/XMLSchema#string

Eugénie Rigault

http://www.w3.org/2001/XMLSchema#string

Marion Richard-Molard

http://www.w3.org/2001/XMLSchema#string

Mathieu Gauthé

http://www.w3.org/2001/XMLSchema#string

Pascale Mariani

http://www.w3.org/2001/XMLSchema#string

Wulfran Cacheux

http://www.w3.org/2001/XMLSchema#string

P2860

Prognostic factors derived from a prospective database dictate clinical biology of anal cancer: the intergroup trial (RTOG 98-11)

Squamous cell carcinoma of the anal canal.

Carcinoma of the anal canal.

Serum CYFRA 21-1 (cytokeratin-19 fragments) is a useful tumour marker for detecting disease relapse and assessing treatment efficacy in breast cancer.

Clinical utility of cytokeratins as tumor markers.

Prognostic value of serum CYFRA21-1 and CEA for non-small-cell lung cancer.

Abdominoperineal resection for anal cancer.

Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial.

Anal cancer: French Intergroup Clinical Practice Guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SNFCP).

Squamous cell carcinoma antigen: a potentially useful prognostic marker in squamous cell carcinoma of the anal canal and margin.

P2888

s12885-018-4335-4

P304

417

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12885-018-4335-4

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-04-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1103254556

http://www.w3.org/2001/XMLSchema#string

P698

29653564

http://www.w3.org/2001/XMLSchema#string

P932

5899349

http://www.w3.org/2001/XMLSchema#string